
Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS-650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor
Keywords: P-گلیکوپروتئین; ADME; antiinfectives; in vitro/in vivo correlations (IVIVC); disposition; hepatic clearance; clearance; metabolism; P-glycoprotein; pharmacokinetics; bioavailability